These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

263 related articles for article (PubMed ID: 18663347)

  • 1. [Lipoprotein (a) and stroke].
    Ferraro M; Spagnuolo V; Sprovieri M; Mauro GF
    Minerva Med; 2008 Aug; 99(4):399-409. PubMed ID: 18663347
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Comparison of the effects of Apo(a) kringle IV-10 and plasminogen kringles on the interactions of lipoprotein(a) with regulatory molecules.
    Xue S; Green MA; LoGrasso PV; Boettcher BR; Madison EL; Curtiss LK; Miles LA
    Thromb Haemost; 1999 Mar; 81(3):428-35. PubMed ID: 10102473
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Relationship of apoE polymorphism with lipoprotein(a), apoA, apoB and lipid levels in atherosclerotic infarct.
    Tascilar N; Dursun A; Ankarali H; Mungan G; Sumbuloglu V; Ekem S; Bozdogan S; Baris S; Aciman E; Cabuk F
    J Neurol Sci; 2009 Feb; 277(1-2):17-21. PubMed ID: 18945448
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Lipoprotein(a). Its importance as an additional atherosclerosis marker].
    Campos E
    Acta Med Port; 1997 Jan; 10(1):87-93. PubMed ID: 9245184
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Lipoprotein(a): a unique risk factor for cardiovascular disease.
    Anuurad E; Boffa MB; Koschinsky ML; Berglund L
    Clin Lab Med; 2006 Dec; 26(4):751-72. PubMed ID: 17110238
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Lipoprotein(a): risk factor for atherosclerotic vascular disease important to take into account in practice].
    Couderc R; Maachi M
    Ann Biol Clin (Paris); 1999; 57(2):157-67. PubMed ID: 10210742
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Impact of apolipoprotein(a) isoform size heterogeneity on the lysine binding function of lipoprotein(a) in early onset coronary artery disease.
    Simó JM; Joven J; Vilella E; Ribas M; Pujana MA; Sundaram IM; Hammel JP; Hoover-Plow JL
    Thromb Haemost; 2001 Mar; 85(3):412-7. PubMed ID: 11307806
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The Kringle V-protease domain is a fibrinogen binding region within Apo(a).
    Xue S; Madison EL; Miles LA
    Thromb Haemost; 2001 Nov; 86(5):1229-37. PubMed ID: 11816712
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Lipoprotein(a) as a marker for coronary heart disease.
    Duriez P; Dallongeville J; Fruchart JC
    Br J Clin Pract Suppl; 1994 Dec; (77):51-8. PubMed ID: 19496273
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Management of Lp(a).
    Brown WV; Ballantyne CM; Jones PH; Marcovina S
    J Clin Lipidol; 2010; 4(4):240-7. PubMed ID: 21122656
    [No Abstract]   [Full Text] [Related]  

  • 11. [Lipoprotein (a)--link between lipid metabolism and coagulation system?].
    Riesen WF
    Schweiz Med Wochenschr; 1991 Dec; 121(49):1813-8. PubMed ID: 1836645
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Lp(a) lipoprotein and plasminogen activity in patients with different etiology of ischemic stroke.
    Petersen NH; Schmied AB; Zeller JA; Plendl H; Deuschl G; Zunker P
    Cerebrovasc Dis; 2007; 23(2-3):188-93. PubMed ID: 17143002
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Research progress in lipoprotein (a): aspects of biochemistry and molecular biology].
    Huang YT
    Sheng Li Ke Xue Jin Zhan; 1996 Jan; 27(1):25-30. PubMed ID: 8731979
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Lipoprotein (a)--a mysterious factor in atherogenesis].
    Jelaković B; Laganović M; Kuzmanić D
    Lijec Vjesn; 2002; 124(11-12):366-71. PubMed ID: 12679978
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A common nonsense mutation in the repetitive Kringle IV-2 domain of human apolipoprotein(a) results in a truncated protein and low plasma Lp(a).
    Parson W; Kraft HG; Niederstätter H; Lingenhel AW; Köchl S; Fresser F; Utermann G
    Hum Mutat; 2004 Dec; 24(6):474-80. PubMed ID: 15523644
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Lipoprotein (a): a prothrombotic risk factor for coronary artery disease.
    Seed M; Doherty E; Stubbs P
    J Cardiovasc Risk; 1995 Jun; 2(3):206-15. PubMed ID: 7584795
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Retinoids inhibit primary cynomolgus monkey hepatocyte lipoprotein(a) levels.
    Ramharack R; Spahr MA; Sekerke CS
    Biochem Biophys Res Commun; 1997 Sep; 238(1):48-52. PubMed ID: 9299449
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Lipoprotein (a), a cardiovascular risk factor: importance of its determination in current clinical practice].
    Couderc R; Maachi M
    J Mal Vasc; 1998 Jun; 23(3):165-75. PubMed ID: 9669219
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cringle conundrums, clotting, cholesterol, and coronaries.
    Luft FC
    J Mol Med (Berl); 1996 Nov; 74(11):637-8. PubMed ID: 8956149
    [No Abstract]   [Full Text] [Related]  

  • 20. Relationship between plasma lipoprotein (a), apolipoprotein (a) phenotypes, and other coronary heart disease risk factors in a Melbourne South Asian population.
    Xiong ZW; Wahlqvist ML; Ibiebele TI; Biegler BM; Balazs ND; Xiong DW; Lim YL
    Clin Biochem; 2004 Apr; 37(4):305-11. PubMed ID: 15003733
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.